scholarly article | Q13442814 |
P50 | author | Jeffery D. Molkentin | Q54858774 |
Brian L Black | Q42412111 | ||
P2093 | author name string | E N Olson | |
P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors | Q24294604 | ||
Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence | Q24300878 | ||
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors | Q24322986 | ||
A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage | Q24324031 | ||
D-MEF2: a MADS box transcription factor expressed in differentiating mesoderm and muscle cell lineages during Drosophila embryogenesis | Q24562839 | ||
MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex | Q24563497 | ||
Drosophila MEF2, a transcription factor that is essential for myogenesis | Q47072848 | ||
Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation | Q59057687 | ||
Mechanism of action of an acidic transcriptional activator in vitro | Q70113517 | ||
Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain gene | Q24611410 | ||
A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes | Q24631256 | ||
Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C | Q24649105 | ||
Crystal structure of MyoD bHLH domain-DNA complex: perspectives on DNA recognition and implications for transcriptional activation | Q27731319 | ||
Myogenin resides in the nucleus and acquires high affinity for a conserved enhancer element on heterodimerization | Q28239333 | ||
Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins | Q28272422 | ||
Functional and physical interactions between mammalian achaete-scute homolog 1 and myocyte enhancer factor 2A | Q28281878 | ||
Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo | Q28298865 | ||
Human SRF-related proteins: DNA-binding properties and potential regulatory targets | Q28300739 | ||
Cooperative transcriptional activation by the neurogenic basic helix-loop-helix protein MASH1 and members of the myocyte enhancer factor-2 (MEF2) family | Q28504632 | ||
MEF2B is a potent transactivator expressed in early myogenic lineages | Q28505977 | ||
Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors | Q28588872 | ||
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C | Q28589290 | ||
MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation | Q33707500 | ||
Muscle-specific expression of SRF-related genes in the early embryo of Xenopus laevis | Q33938625 | ||
MyoD family: a paradigm for development? | Q34271215 | ||
The MADS-box family of transcription factors | Q34310228 | ||
Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression | Q34555693 | ||
D-mef2: a Drosophila mesoderm-specific MADS box-containing gene with a biphasic expression profile during embryogenesis | Q35644544 | ||
A class of activation domains interacts directly with TFIIA and stimulates TFIIA-TFIID-promoter complex assembly | Q36556030 | ||
A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing | Q36647589 | ||
Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo | Q36698715 | ||
The mouse MRF4 promoter is trans-activated directly and indirectly by muscle-specific transcription factors. | Q36715561 | ||
Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products | Q36735034 | ||
The Basic Region of Myogenin Cooperates with Two Transcription Activation Domains To Induce Muscle-Specific Transcription | Q36808538 | ||
Mutagenesis of the myogenin basic region identifies an ancient protein motif critical for activation of myogenesis | Q37541258 | ||
A series of mutations in the D-MEF2 transcription factor reveal multiple functions in larval and adult myogenesis in Drosophila. | Q38292216 | ||
Muscle-specific transcriptional activation by MyoD | Q38334158 | ||
The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation | Q38341599 | ||
Regulation of Muscle Differentiation by the MEF2 Family of MADS Box Transcription Factors | Q40432858 | ||
Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with MyoD. | Q41428425 | ||
Co-operativity of functional domains in the muscle-specific transcription factor Myf-5 | Q41523726 | ||
Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12 | Q41624448 | ||
Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis | Q42803715 | ||
Tissue-specific gene activation by MyoD: determination of specificity by cis-acting repression elements | Q42833957 | ||
Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila | Q47072813 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 69-77 | |
P577 | publication date | 1998-01-01 | |
P1433 | published in | Molecular and Cellular Biology | Q3319478 |
P1476 | title | Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2 | |
P478 | volume | 18 |
Q30630118 | A zebrafish homolog of the serum response factor gene is highly expressed in differentiating embryonic myocytes |
Q37218221 | Acetylcholinesterase expression in muscle is specifically controlled by a promoter-selective enhancesome in the first intron |
Q24554516 | Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C |
Q36062300 | Activation of AMP-Activated Protein Kinase and Stimulation of Energy Metabolism by Acetic Acid in L6 Myotube Cells |
Q37035007 | Alternative requirements for Vestigial, Scalloped, and Dmef2 during muscle differentiation in Drosophila melanogaster |
Q27308063 | Cell-Autonomous and Non-Cell-Autonomous Regulation of a Feeding State-Dependent Chemoreceptor Gene via MEF-2 and bHLH Transcription Factors |
Q44020755 | Characterization of CeHDA-7, a class II histone deacetylase interacting with MEF-2 in Caenorhabditis elegans |
Q42456711 | Characterization of the human skeletal muscle glycogen synthase gene (GYS1) promoter |
Q77726488 | Combinatorial interactions regulate cardiac expression of the murine adenylosuccinate synthetase 1 gene |
Q50793385 | Comparing the transcriptional profile of mesenchymal cells to cardiac and skeletal muscle cells. |
Q24674713 | Computational analysis of tissue-specific combinatorial gene regulation: predicting interaction between transcription factors in human tissues |
Q34031825 | Contributions of selective knockout studies to understanding cholinesterase disposition and function. |
Q28581318 | Cooperative interaction between the basic helix-loop-helix transcription factor dHAND and myocyte enhancer factor 2C regulates myocardial gene expression |
Q40102723 | Creatine enhances differentiation of myogenic C2C12 cells by activating both p38 and Akt/PKB pathways |
Q45115264 | Creatine feeding increases GLUT4 expression in rat skeletal muscle |
Q28594728 | Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1 |
Q40181522 | Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle |
Q42412056 | Determinants of myogenic specificity within MyoD are required for noncanonical E box binding |
Q40640633 | Differential binding of quadruplex structures of muscle-specific genes regulatory sequences by MyoD, MRF4 and myogenin |
Q35167424 | Differentiation and fiber type-specific activity of a muscle creatine kinase intronic enhancer |
Q33780318 | Distinct functions of alternatively spliced isoforms encoded by zebrafish mef2ca and mef2cb |
Q52126593 | Drosophila MEF2 is a direct regulator of Actin57B transcription in cardiac, skeletal, and visceral muscle lineages. |
Q36741254 | ERK5 promotes Src-induced podosome formation by limiting Rho activation |
Q46095654 | Effects of acetate on lipid metabolism in muscles and adipose tissues of type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats |
Q28566172 | Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene |
Q39450188 | Establishment of distinct MyoD, E2A, and twist DNA binding specificities by different basic region-DNA conformations |
Q33269436 | Fast skeletal muscle myosin heavy chain gene cluster of medaka Oryzias latipes enrolled in temperature adaptation |
Q24599616 | GATA-dependent recruitment of MEF2 proteins to target promoters |
Q41908985 | GLUT4 enhancer factor (GEF) interacts with MEF2A and HDAC5 to regulate the GLUT4 promoter in adipocytes |
Q28216916 | Genomic organization and promoter regulation of human cytochrome c oxidase subunit VII heart/muscle isoform (COX7AH) |
Q24623607 | HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo |
Q42458801 | Human skeletal muscle cell differentiation is associated with changes in myogenic markers and enhanced insulin-mediated MAPK and PKB phosphorylation. |
Q30849535 | Identification of two regulatory binding sites which confer myotube specific expression of the mono-ADP-ribosyltransferase ART1 gene |
Q36404030 | Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. |
Q40442292 | Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells |
Q80560259 | Innervation-dependent and fiber type-specific transcriptional regulation of the slow myosin heavy chain 2 promoter in avian skeletal muscle fibers |
Q35097402 | Insulin and LiCl synergistically rescue myogenic differentiation of FoxO1 over-expressed myoblasts |
Q50287827 | Interaction of MyoD:E protein with MEF2 |
Q33778990 | Intramolecular regulation of MyoD activation domain conformation and function |
Q90239789 | Lipin1 is required for skeletal muscle development by regulating MEF2c and MyoD expression |
Q42457102 | MEF2 activation in differentiated primary human skeletal muscle cultures requires coordinated involvement of parallel pathways |
Q88636857 | MEF2‑activated long non‑coding RNA PCGEM1 promotes cell proliferation in hormone‑refractory prostate cancer through downregulation of miR‑148a |
Q28587073 | Molecular characterization and expression of the gene for mouse NAD+:arginine ecto-mono(ADP-ribosyl)transferase, Art1 |
Q40735023 | Mouse dystrophin enhancer preferentially targets lacZ expression in skeletal and cardiac muscle. |
Q52182756 | Muscle differentiation: more complexity to the network of myogenic regulators. |
Q24669679 | Mutation of MEF2A in an inherited disorder with features of coronary artery disease |
Q35071008 | MyoD synergizes with the E-protein HEB beta to induce myogenic differentiation. |
Q34657364 | MyoD targets TAF3/TRF3 to activate myogenin transcription. |
Q28592398 | MyoR: a muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD |
Q34173695 | Myofibroblasts: molecular crossdressers. |
Q34266794 | NFATc1 controls skeletal muscle fiber type and is a negative regulator of MyoD activity |
Q28218291 | Overexpression of chemokine-like factor 2 promotes the proliferation and survival of C2C12 skeletal muscle cells |
Q39838822 | P/CAF rescues the Bhlhe40-mediated repression of MyoD transactivation |
Q24297205 | PC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C. |
Q24626949 | PC4/Tis7/IFRD1 stimulates skeletal muscle regeneration and is involved in myoblast differentiation as a regulator of MyoD and NF-kappaB |
Q39755305 | Quadruplex structures of muscle gene promoter sequences enhance in vivo MyoD-dependent gene expression |
Q22008562 | Regulation of the MEF2 family of transcription factors by p38 |
Q34350083 | Skeletal muscle programming and re-programming |
Q34322871 | Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications |
Q47263553 | Something to SNF about |
Q40768023 | The coactivator-associated arginine methyltransferase is necessary for muscle differentiation: CARM1 coactivates myocyte enhancer factor-2. |
Q40749592 | The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells |
Q42830974 | The mouse dystrophin enhancer is regulated by MyoD, E-box-binding factors, and by the serum response factor |
Q50064070 | The myogenic regulatory factors, determinants of muscle development, cell identity and regeneration. |
Q35193858 | The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. |
Q37382974 | The transcription factor Mef2 links the Drosophila core clock to Fas2, neuronal morphology, and circadian behavior |
Q35266364 | The transcription factor neural retina leucine zipper (NRL) controls photoreceptor-specific expression of myocyte enhancer factor Mef2c from an alternative promoter |
Q40637660 | Time course and side-by-side analysis of mesodermal, pre-myogenic, myogenic and differentiated cell markers in the chicken model for skeletal muscle formation |
Q90099425 | Transcription Factor-Directed Re-wiring of Chromatin Architecture for Somatic Cell Nuclear Reprogramming toward trans-Differentiation |
Q33886670 | Transcription factor BETA2 acts cooperatively with E2A and PDX1 to activate the insulin gene promoter |
Q35054057 | Transcription factor MEF2A mutations in patients with coronary artery disease |
Q43120109 | Transcriptional features of genomic regulatory blocks |
Q41962292 | Zebrafish Mef2ca and Mef2cb are essential for both first and second heart field cardiomyocyte differentiation. |
Q46055034 | mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo |
Q24554203 | p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps |
Q40543190 | p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci |
Q44652035 | pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation |
Search more.